Complement-based Drug Development 2020
October 13 - 15, 2020 - MA USGeorgina Fitzgerald
info@hansonwade.com
Phone:+16174554188
The 2020 meeting is bringing you the latest clinical advancements in complement therapeutics both through physical meeting taking place in Boston and Virtually. With the ongoing COVID-19 pandemic, complement therapies are offering a glimmer of hope for us all. This year you can expect to hear from industry leaders showcasing the next generation of drugs aimed at complement system modulation, longer durations of action, organ-specific delivery and intracellular targeting. The 2020 meeting is bringing you the latest clinical advancements in complement therapeutics. With the ongoing COVID-19 pandemic, . Attend this event to: - Learn how different global leaders are employing state-the-art strategies to manipulate specific areas of the complement cascade within a range of disease indications - Analyze how to translate data from animal models into the human analog - Take advantage of three days of unparalleled networking and come away with the knowledge to overcome your end-to-end challenges from preclinical modelling to streamlining process development - Learn how to leverage translational biomarkers to accelerate development of complement directed therapies - Hear an update from the latest results coming out of the clinic